Which antiarrhythmic drug has a metabolite with the same action?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Enhance your knowledge with the Ciulla Clinical Chemistry Test. Study with interactive quizzes, featuring flashcards and multiple-choice questions. Each question offers hints and explanations for better understanding. Prepare effectively and excel in your exam!

Multiple Choice

Which antiarrhythmic drug has a metabolite with the same action?

Explanation:
Some antiarrhythmics have active metabolites that continue to produce the same type of antiarrhythmic effect as the parent drug. In this case, procainamide is metabolized to N-acetylprocainamide, which preserves antiarrhythmic activity. NAPA mainly behaves as a class III drug, blocking potassium channels and prolonging repolarization, which extends the effective refractory period much like procainamide does. This metabolite thus contributes to the overall rhythm-stabilizing action. The other drugs listed don’t have well-known active metabolites that share their exact antiarrhythmic mechanism to the same extent, so they don’t fit this pattern as clearly.

Some antiarrhythmics have active metabolites that continue to produce the same type of antiarrhythmic effect as the parent drug. In this case, procainamide is metabolized to N-acetylprocainamide, which preserves antiarrhythmic activity. NAPA mainly behaves as a class III drug, blocking potassium channels and prolonging repolarization, which extends the effective refractory period much like procainamide does. This metabolite thus contributes to the overall rhythm-stabilizing action.

The other drugs listed don’t have well-known active metabolites that share their exact antiarrhythmic mechanism to the same extent, so they don’t fit this pattern as clearly.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy